期刊
CURRENT PAIN AND HEADACHE REPORTS
卷 16, 期 3, 页码 191-198出版社
SPRINGER
DOI: 10.1007/s11916-012-0256-0
关键词
Neuropathic pain; Epidemiology; Prevalence; Incidence; Chronic pain; Screening tools; Neuropathy; Diabetic neuropathy; Postherpetic neuralgia
资金
- Pfizer
Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available. In one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease; on the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile to consider neuropathic pain as a distinct condition. However, there are important specific disease-based factors that need to be considered separately. Estimates of prevalence that are based on specific causes of neuropathic pain tend to be lower (1-2%) than those that are based on reports of the classic symptoms (6-8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic factors, still needs to be assessed at a population level.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据